3.800 s

-0.120 (-3.06%)
Range 3.760 - 3.920   (4.26%)
Open 3.870
Previous Close 3.920
Buy Price 3.800
Buy Volume 47.1
Sell Price 3.810
Sell Volume 76.9
Volume 11,587.7
Value -
Remark s
Measurement Type Value
EPS (SGD) 0.051
Trailing EPS (SGD) -0.044
NAV (SGD) 0.565
Cash In Hand (SGD) 0.242
Dividend -
Dividend Yield (%) -
PE 8.781
Trailing PE -
Price / NAV 0.787
Price / Cash In Hand 1.84
Issued & Paid-up Shares 45,875,000
Treasury Shares 950,000
Market Cap (M) 20.414
Par Value (SGD) n.a.
Beta - 75 Days -4.58
R-Squared - 75 Days(%) 1.53
Beta - 500 Days -0.541
R-Squared - 500 Days(%) 0.23
ISIN Code SG1BB3000009
Under CPF Investment Scheme (CPFIS) No
Index Components FTSE ST All-Share Health Care Index
Delayed prices. Updated at 03 Apr 2020 04:50.
Data powered by
View All Events

About Star Pharm^

STAR Pharmaceutical Limited is an investment holding company. The principal activities of the subsidiaries are those relating to the development, manufacturing and trading of pharmaceutical products. The Company operates in the development, manufacturing and trading of pharmaceutical products segment. The Company and its subsidiaries are engaged in the manufacture and sale of both western and Traditional Chinese Medicine (TCM)-formulated prescription drugs. The Company's range of pharmaceutical products include antibiotics, cerebrovascular drugs and cardiovascular drugs, and other specialized drugs manufactured in-house in various dosages and administration forms from powder injections, lyophilized powder injections, liquid injections to tablets, capsules and granules. It has approximately 820 distributors to hospitals, clinics and pharmacies. The Company has a manufacturing facility based in Qionghai City, Hainan Province of People's Republic of China.